Abstract
This meta-analysis compares the efficacy of high-flow nasal cannula (HFNC) with conventional oxygen therapy in patients with acute heart failure (AHF). We comprehensively searched the PubMed, Embase, Cochrane Library, Chinese Sino-Med, China National Knowledge Infrastructure, and Chinese WanFang Med Online databases and identified 9 randomized controlled trials with 689 patients that compared HFNC with conventional oxygen therapy. We found that HFNC use in patients with AHF resulted in a significant improvement in their heart rate, respiratory rate, brain natriuretic peptide level, oxygen saturation, partial pressure of oxygen, intubation rate, left ventricular ejection fraction, and length of hospitalization.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
